Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12762)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through May 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song MJ. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3843-3849 [PMID: 25852268 DOI: 10.3748/wjg.v21.i13.3843] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i13/3843.htm |
| Number | Citing Articles |
| 1 |
Carlotta Salvatori, Diego Trucco, Ignazio Niosi, Leonardo Ricotti, Lorenzo Vannozzi. Biomimetic and Biohybrid Systems. Lecture Notes in Computer Science 2023; 14158: 378 doi: 10.1007/978-3-031-39504-8_26
|
| 2 |
P. G. Tarazov. Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma. Review of the Literature. Journal of oncology: diagnostic radiology and radiotherapy 2023; 6(4): 62 doi: 10.37174/2587-7593-2023-6-4-62-67
|
| 3 |
Shengzhou Li, Jiaxuan Xu, Hongya Zhang, Jiaze Hong, Yuexiu Si, Tong Yang, Yujing He, Derry Minyao Ng, Dingcheng Zheng. The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Chemotherapy 2021; 66(4): 124 doi: 10.1159/000518257
|
| 4 |
Jui-Hu Hsiao, Cheng-Chung Tsai, Tsung-Jung Liang, Chia-Ling Chiang, Huei-Lung Liang, I-Shu Chen, Yu-Chia Chen, Po-Ming Chang, Nan-Hua Chou, Being-Whey Wang. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. International Journal of Surgery 2017; 45: 35 doi: 10.1016/j.ijsu.2017.07.071
|
| 5 |
Wei-Lun Tsai, Wei-Chi Sun, Wen-Chi Chen, Chia-Ling Chiang, Huey-Shyan Lin, Huei-Lung Liang, Jin-Shiung Cheng. Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma. Medicine 2020; 99(32): e21489 doi: 10.1097/MD.0000000000021489
|
| 6 |
Grigorios Christodoulidis, Dimitra Bartzi, Konstantinos E Koumarelas. Anticipation for hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2025; 17(2): 100505 doi: 10.4251/wjgo.v17.i2.100505
|
| 7 |
Wen-Tsan Chang, Yung-Ding Bow, Pei-Jung Fu, Chia-Yang Li, Chang-Yi Wu, Yi-Hua Chang, Yen-Ni Teng, Ruei-Nian Li, Mei-Chin Lu, Yi-Chang Liu, Chien-Chih Chiu, Cristina Angeloni. A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/7689045
|
| 8 |
Xiaoya Liu, Xueying Wang, Yucheng Luo, Meijuan Wang, Zijian Chen, Xiaoyu Han, Sijia Zhou, Jiahao Wang, Jian Kong, Hanry Yu, Xiaobo Wang, Xiaoying Tang, Qiongyu Guo. A 3D Tumor‐Mimicking In Vitro Drug Release Model of Locoregional Chemoembolization Using Deep Learning‐Based Quantitative Analyses. Advanced Science 2023; 10(11) doi: 10.1002/advs.202206195
|
| 9 |
Apurva Bonde, Alice W. Fung, Skye C. Mayo, Peter Li, Brett S. Walker, Sriram Jaganathan, Nadine Mallak, Elena K. Korngold. Imaging of the hepatic arterial infusion pump: Primer for radiologists. Clinical Imaging 2024; 105: 110022 doi: 10.1016/j.clinimag.2023.110022
|
| 10 |
Tao Xue, Hongbin Yu, Wenming Feng, Yao Wang, Shiyong Wu, Lili Wang, Peiqin Zhu, Jianming Guan, Quan Sun. Efficacy and Safety of Hepatic Arterial Infusion Therapy with Cinobufacini in Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Retrospective Cohort Study. Cancer Management and Research 2024; : 163 doi: 10.2147/CMAR.S440017
|
| 11 |
Lipika Goyal, Motaz Qadan, Andrew X. Zhu. Another Treatment Option for Advanced Hepatocellular Carcinoma With Portal Vein Thrombosis in China. JAMA Oncology 2019; 5(7): 938 doi: 10.1001/jamaoncol.2019.0249
|
| 12 |
Michael Hsu, Muneeb Ahmed, Ammar Sarwar. Indications and Best Practices for Intra-arterial Therapies to Treat Hepatocellular Carcinoma. Current Hepatology Reports 2018; 17(4): 399 doi: 10.1007/s11901-018-0428-4
|
| 13 |
Tengfei Si, Qing Shao, Wayel Jassem, Yun Ma, Nigel Heaton. Optimal candidates and surrogate endpoints for HAIC versus Sorafenib in hepatocellular carcinoma: an updated systematic review and meta-analysis. International Journal of Surgery 2025; 111(1): 1203 doi: 10.1097/JS9.0000000000001889
|
| 14 |
Jaejun Lee, Pil Soo Sung, Hyun Yang, Soon Kyu Lee, Hee Chul Nam, Sun Hong Yoo, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Jung Hyun Kwon, Jeong Won Jang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC. Journal of Clinical Medicine 2020; 9(12): 4121 doi: 10.3390/jcm9124121
|
| 15 |
Ming‐Da Wang, Xue‐Jun Xu, Ke‐Chun Wang, Yong‐Kang Diao, Jia‐Hao Xu, Li‐Hui Gu, Lan‐Qing Yao, Chao Li, Guo‐Yue Lv, Tian Yang. Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities. Cancer Science 2024; 115(7): 2159 doi: 10.1111/cas.16194
|
| 16 |
JinSuo Chen, LiNa Wang, XueMei Wu, ZhiJie Ding, WenXi Cao, LeiLei Yang, YongPing Zhou, Li Xia, Zhao Song. MicroRNA-34b-5p increases chemosensitivity of hepatocellular carcinoma cells. Molecular & Cellular Toxicology 2025; 21(1): 173 doi: 10.1007/s13273-024-00431-z
|
| 17 |
Lingbo Hu, Jiangying Lin, Xingpeng Shi, Aidong Wang. Efficacy of transarterial therapy combined with first-line tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a network meta-analysis. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03098-3
|
| 18 |
Hee Chul Nam, Pil Soo Sung, Ho Jong Chun, Dong Goo Kim, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon. Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Liver Cancer 2019; 19(1): 64 doi: 10.17998/jlc.19.1.64
|
| 19 |
Po-Hsu Su, Chun-Feng Wu. Hepatic Arterial Infusion Chemotherapy for Liver Tumor Control in a Patient with Liver Metastasis from Lung Small Cell Carcinoma, a Case Report and Discussion. Journal of Cancer Research and Practice 2022; 9(2): 69 doi: 10.4103/JCRP.JCRP_29_21
|
| 20 |
Akira Saito, Joji Kitayama, Ryozo Nagai, Kenichi Aizawa. Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review. Pharmaceutics 2023; 15(6): 1664 doi: 10.3390/pharmaceutics15061664
|
| 21 |
Mahmoud Aryan, Ellery Altshuler, Xia Qian, Wei Zhang. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99837
|
| 22 |
Tomoko Tadokoro, Joji Tani, Asahiro Morishita, Koji Fujita, Tsutomu Masaki, Hideki Kobara. The Treatment of Hepatocellular Carcinoma with Major Vascular Invasion. Cancers 2024; 16(14): 2534 doi: 10.3390/cancers16142534
|
| 23 |
Di Ma, Juan Wang, Lu Liu, Meiqi Chen, Zhiyong Wang. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07447-3
|
| 24 |
Suqi Zhu, Yahan Yu, Mingqi Yang, Xin Liu, Mingkai Lai, Jieren Zhong, Xiaoguang Zhao, Ligong Lu, Yanyan Liu. Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review. Expert Review of Anticancer Therapy 2024; 24(6): 423 doi: 10.1080/14737140.2024.2346624
|
| 25 |
Hong Liu, Yiyang Xu, Jingyi Xiang, Li Long, Shon Green, Zhiyuan Yang, Bryan Zimdahl, Jingwei Lu, Neal Cheng, Lucas H. Horan, Bin Liu, Su Yan, Pei Wang, Juan Diaz, Lu Jin, Yoko Nakano, Javier F. Morales, Pengbo Zhang, Lian-xing Liu, Binnaz K. Staley, Saul J. Priceman, Christine E. Brown, Stephen J. Forman, Vivien W. Chan, Cheng Liu. Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer. Clinical Cancer Research 2017; 23(2): 478 doi: 10.1158/1078-0432.CCR-16-1203
|
| 26 |
Ziyou Wang, Hua Zhang, Jiahui Zhou, Xiangning Zhang, Liyong Chen, Kangxing Chen, Zunnan Huang. Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle. Cancer Chemotherapy and Pharmacology 2016; 78(6): 1143 doi: 10.1007/s00280-016-3171-y
|
| 27 |
Jae Hwan Lee, Hyungwon Moon, Hyounkoo Han, In Joon Lee, Doyeon Kim, Hak Jong Lee, Shin-Woo Ha, Hyuncheol Kim, Jin Wook Chung. Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors. Cancers 2019; 11(4): 581 doi: 10.3390/cancers11040581
|
| 28 |
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
|
| 29 |
Reham M. M. El-Hazek, Nashwa H. Zaher, Mostafa G. M. El-Gazzar, Noha A. Fadel, Walaa A. El-Sabbagh. Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-40832-z
|
| 30 |
Taro Takami, Takahiro Yamasaki, Issei Saeki, Toshihiko Matsumoto, Yutaka Suehiro, Isao Sakaida. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function. World Journal of Gastroenterology 2016; 22(32): 7252-7263 doi: 10.3748/wjg.v22.i32.7252
|
| 31 |
Elwin Tham, Carl Schmidt, Anthony Scholer. Hepatic Arterial Infusion for Malignancy. 2025; : 221 doi: 10.1007/978-3-031-74935-3_19
|
| 32 |
文豪 寇. Progress in Non-Surgical Treatment of Primary Hepatocellular Carcinoma with Combined Portal Vein Carcinoma Thrombosis. Advances in Clinical Medicine 2023; 13(07): 11779 doi: 10.12677/ACM.2023.1371651
|
| 33 |
Jae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Suho Kim, Jung Suk Oh, Ho Jong Chun, Pil Soo Sung. Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study. Abdominal Radiology 2024; 49(9): 3127 doi: 10.1007/s00261-024-04308-6
|
| 34 |
Sadahisa Ogasawara, Keisuke Koroki, Hiroaki Kanzaki, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Naoya Kato. Changes in therapeutic options for hepatocellular carcinoma in Asia. Liver International 2022; 42(9): 2055 doi: 10.1111/liv.15101
|
| 35 |
Wenbo Guo, Jian Gao, Wenquan Zhuang, Zhiqiang Wu, Bin Li, Song Chen. Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score‐matching cohort study. JGH Open 2020; 4(3): 477 doi: 10.1002/jgh3.12285
|
| 36 |
Min Kyu Kang, Jung Gil Park, Heon Ju Lee. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma. Medicine 2018; 97(17): e0611 doi: 10.1097/MD.0000000000010611
|
| 37 |
Ji Kim, Hee-Chul Nam, Chang-Wook Kim, Hee Cho, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Hyun Yang, Si Bae, Suho Kim, Jung Oh, Ho Chun, Chang Jeon, Jaegyoon Ahn, Pil Sung. Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study. Cancers 2023; 15(17): 4233 doi: 10.3390/cancers15174233
|
| 38 |
Rongbin Yue, Xiqiang Liu. Impact of Transarterial Chemoembolization or Hepatic Artery Infusion Chemotherapy on Liver Function after Hepatocellular Carcinoma Resection: An Observational Study. Digestion 2023; 104(4): 291 doi: 10.1159/000528750
|
| 39 |
Tao Wan, Xueqin Gan, Weijie Xiong. Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2024; 20(6): 747 doi: 10.1111/ajco.14105
|
| 40 |
Ying Liu, Yuzhu Wang, Xinkun Guo, Yifeng He, Jian Zhou, Qianzhou Lv, Xiaowu Huang, Xiaoyu Li. Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.709278
|
| 41 |
Chia-Bang Chen, Chun-Min Chen, Ruo-Han Tzeng, Chen-Te Chou, Pei-Yuan Su, You-Chuen Hsu, Cheng-Da Yang. Combining HAIC and Sorafenib as a Salvage Treatment for Patients with Treatment-Failed or Advanced Hepatocellular Carcinoma: A Single-Center Experience. Journal of Clinical Medicine 2023; 12(5): 1887 doi: 10.3390/jcm12051887
|
| 42 |
Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung. Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma. Oncology Letters 2024; 28(2) doi: 10.3892/ol.2024.14521
|
| 43 |
Hao Sun, Bing Ma, Ning Sun, Han Bai, Xuejian Li, Chengshuo Zhang. Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis. Critical Reviews in Oncology/Hematology 2023; 189: 104083 doi: 10.1016/j.critrevonc.2023.104083
|
| 44 |
A.H.K. Abdelmaksoud, A.O. Abdelaziz, M.M. Nabeel, I. Hamza, T.M. Elbaz, H.I. Shousha, R.S.M. Abdelhady, R. Lithy. Hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein thrombosis: a case–control study. Clinical Radiology 2021; 76(9): 709.e1 doi: 10.1016/j.crad.2021.03.022
|
| 45 |
Bradley J. GIROD, Asha KANDATHIL. A review of F-18 fluorodeoxyglucose PET/CT in the evaluation and treatment of hepatobiliary tumors. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2025; 68(4) doi: 10.23736/S1824-4785.24.03574-X
|
| 46 |
Yanying Li, Jingliang Wu, Qiao Lu, Xuemin Liu, Jiaxuan Wen, Xiaohui Qi, Jianhao Liu, Bo Lian, Bo Zhang, Hengyi Sun, Guixiang Tian. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma. International Journal of Nanomedicine 2022; : 2559 doi: 10.2147/IJN.S366180
|
| 47 |
Georgios A. Sideris, Savvas Tsaramanidis, Aikaterini T. Vyllioti, Njogu Njuguna. The Role of Branched-Chain Amino Acid Supplementation in Combination with Locoregional Treatments for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis. Cancers 2023; 15(3): 926 doi: 10.3390/cancers15030926
|
| 48 |
Yasuteru Kondo, Tatsuki Morosawa, Soichiro Minami, Yasuhito Tanaka. DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21472-1
|
| 49 |
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemotherapy and Pharmacology 2018; 82(3): 469 doi: 10.1007/s00280-018-3638-0
|
| 50 |
Jessica Elderkin, Najeeb Al Hallak, Asfar S. Azmi, Hussein Aoun, Jeffrey Critchfield, Miguel Tobon, Eliza W. Beal. Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management. Cancers 2023; 15(21): 5118 doi: 10.3390/cancers15215118
|
| 51 |
Christina G. Dalzell, Amy C. Taylor, Sarah B. White. New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma. Cancers 2023; 15(24): 5749 doi: 10.3390/cancers15245749
|
| 52 |
Ji Yeon Lee, Jaejun Lee, Suho Kim, Jae-sung Yoo, Ji Hoon Kim, Keungmo Yang, Ji Won Han, Jeong Won Jang, Jong Yong Choi, Seung Kew Yoon, Ho Jong Chun, Jung Suk Oh, Pil Soo Sung. Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1495321
|
| 53 |
Minhyung Kim, Colin A. Powers, Leslie I. Curtin, Daniel T. Fisher, Sandra Sexton, Katerina V. Gurova, Joseph J. Skitzki, Renuka V. Iyer. A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks. Journal of Surgical Research 2020; 251: 126 doi: 10.1016/j.jss.2020.02.002
|
| 54 |
Masafumi Ikeda, Takuji Okusaka, Yozo Sato, Junji Furuse, Shuichi Mitsunaga, Hideki Ueno, Chigusa Morizane, Yoshitaka Inaba, Tatsushi Kobayashi, Yasuaki Arai. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma. Japanese Journal of Clinical Oncology 2017; 47(6): 512 doi: 10.1093/jjco/hyx038
|
| 55 |
Elena Fountzilas, Elangovan Krishnan, Filip Janku, Siqing Fu, Daniel D. Karp, Aung Naing, Vivek Subbiah, David S. Hong, Sarina A. Piha-Paul, David J. Vining, Apostolia-Maria Tsimberidou. A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement. Cancer Chemotherapy and Pharmacology 2018; 82(5): 877 doi: 10.1007/s00280-018-3680-y
|
| 56 |
Yuhua Wen, Lianghe Lu, Jie Mei, Yihong Ling, Renguo Guan, Wenping Lin, Wei Wei, Rongping Guo. Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis. Journal of Hepatocellular Carcinoma 2024; : 665 doi: 10.2147/JHC.S453250
|
| 57 |
Xiao-long Wu, Ying Chen, Wen-cui Kong, Zhong-quan Zhao. Amyloid precursor protein regulates 5-fluorouracil resistance in human hepatocellular carcinoma cells by inhibiting the mitochondrial apoptotic pathway. Journal of Zhejiang University-SCIENCE B 2020; 21(3): 234 doi: 10.1631/jzus.B1900413
|
| 58 |
Kazuya SASAKI, Toshiki SAKAMOTO, So MATSUI, Misao SAITO. Multiple Early Intrahepatic Recurrences of Hepatocellular Carcinoma after Hepatectomy Successfully Treated by Hepatic Arterial Chemotherapy. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2018; 79(7): 1506 doi: 10.3919/jjsa.79.1506
|
| 59 |
Fangmin Chen, Yifan Fang, Ruirui Zhao, Jingqing Le, Bingchen Zhang, Rui Huang, Zixuan Chen, Jingwei Shao. Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma. European Journal of Medicinal Chemistry 2019; 179: 916 doi: 10.1016/j.ejmech.2019.06.070
|
| 60 |
Shousheng Liu, Jinfa Lai, Ning Lyu, Qiankun Xie, Huijiao Cao, Dabiao Chen, Meng He, Bei Zhang, Ming Zhao. Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.582504
|
| 61 |
Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner. Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome. memo - Magazine of European Medical Oncology 2022; 15(1): 5 doi: 10.1007/s12254-021-00791-5
|